Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-Center, Open Label, Single Arm Clinical Trial Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor System in NYHA Class III Heart Failure Patients (PROACTIVE- HF Trial)

NCT04089059 is registered in ClinicalTrials.gov with Endotronix, Inc. as lead sponsor.

NCT NCT04089059
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04089059 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-Center, Open Label, Single Arm Clinical Trial Evaluating the Safety and Efficacy of the Cordella™ Pulmonary Artery Sensor System in NYHA Class III Heart Failure Patients (PROACTIVE- HF Trial)
Lead sponsor
Endotronix, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 10, 2020
Completion date
April 30, 2028
Enrollment
738 (actual)
Sites
74

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure nyha class iii